Managing chronic arthritis.
Many compounds are being investigated for the control of symptoms of osteoarthritis in people and animals. Ideally, treatment should include analgesia, inflammation control, and chondroprotection. With further progress in this area, combination therapies tailored to the needs of the individual animal should enable us to maximize efficacy and minimize side effects. Only a few of the newer therapies and pharmaceutic agents have been investigated in the horse, however. With more rigorous investigation, they may be determined to be ineffective or unsafe. Meanwhile, as much information should be gathered from manufacturers as possible so as to ensure that appropriate recommendations are made.
Malone
Erin D
ED
Department of Clinical and Population Sciences, 225K Veterinary Teaching Hospitals, 1365 Gortner Avenue, St. Paul, MN 55108, USA. malon001@tc.umn.edu
D000375:Aging / Q000502:physiology*; D000700:Analgesics / Q000627:therapeutic use*; D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D001168:Arthritis / Q000188:drug therapy / Q000601:surgery / Q000628:therapy / Q000662:veterinary*; D005260:Female; D006734:Horse Diseases / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D006736:Horses; D008297:Male; D010003:Osteoarthritis / Q000188:drug therapy / Q000601:surgery / Q000628:therapy / Q000662:veterinary; D010146:Pain / Q000188:drug therapy / Q000209:etiology / Q000662:veterinary; D010805:Physical Conditioning, Animal
D000700:Analgesics; D000894:Anti-Inflammatory Agents, Non-Steroidal